宣泰医药：吴华峰辞去公司副总经理职务

Group 1 - The board of directors of Shanghai Xuantai Pharmaceutical Technology Co., Ltd. received a resignation letter from Deputy General Manager Wu Huafeng on September 30, 2025, citing personal reasons for his departure [1] - After resigning, Wu Huafeng will no longer hold any other positions within the company [1] Group 2 - There is a growing concern in the industry regarding consumer loans, as banks are now demanding invoices to be uploaded within seven days, leading to anxiety among some individuals while others are finding ways to profit from this situation by offering invoice services [1]